Snowball logo
logo
3001

Zhejiang Jolly Pharmaceutical Co Ltd

300181 SHE
¥14.90¥0.00  (0%)
Estimate
P/E
15.9
EPS
0.94
Beta
0.145
Growth
Revenue, YoY
8.9%
Net income, YoY
10.18%
FCF, YoY
111.42%
Forecast
P/E (FWD)
11.8
EPS (FWD)
1.26
Dividends
Dividend yield
2.35%
Annual payout
¥0.35
Next ex. div date
May 28, 27
Payout
65.54%
Div.growth, 5y
97.44%
Div.rating
About the company
Ticker
300181
ISIN
CNE100001096
Country
China
Sector (GICS)
Healthcare
Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People's Republic of China and internationally. The company offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. It also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, the company offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, it provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, it offers materials, such as cephalosporin sinensis, fermented cordyceps, and Wuling powders. It invests and participates in the medical services of Deqing No.3 People's Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co.,LTD in 1998. The company was founded in 1995 and is based in Huzhou, China.

Frequently asked questions

What sector does Zhejiang Jolly Pharmaceutical Co Ltd (300181) operate in?

Zhejiang Jolly Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.

What is Zhejiang Jolly Pharmaceutical Co Ltd (300181) current stock price?

As of the latest data, Zhejiang Jolly Pharmaceutical Co Ltd stock price is CN¥14.90, with a previous close of CN¥14.90.

What is Zhejiang Jolly Pharmaceutical Co Ltd (300181) current market capitalization?

Zhejiang Jolly Pharmaceutical Co Ltd market cap is approximately 10.45 billion.

What is Zhejiang Jolly Pharmaceutical Co Ltd (300181) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.94, and the forward EPS is CN¥1.26.

What is Zhejiang Jolly Pharmaceutical Co Ltd (300181) Price-to-Earnings (P/E) ratio?

Zhejiang Jolly Pharmaceutical Co Ltd current P/E ratio is 15.85, with a forward P/E of 11.83.

Does Zhejiang Jolly Pharmaceutical Co Ltd (300181) pay dividends?

Yes. Zhejiang Jolly Pharmaceutical Co Ltd pays annual dividends with an annualized yield of 2.35% and an estimated annual payout of CN¥0.35 per share.

When is the next ex-dividend date for Zhejiang Jolly Pharmaceutical Co Ltd (300181)?

The next ex-dividend date is scheduled for May 28, 2027.

What is Zhejiang Jolly Pharmaceutical Co Ltd (300181) beta (volatility) score?

Zhejiang Jolly Pharmaceutical Co Ltd has a beta of 0.145, indicating lower volatility than the overall market.